diabetes
Optithera, ELNA Medical Group, Génome Québec Partner on Saliva-Based Type 2 Diabetes Test
Optithera is developing a prognostic test to asses the risk that patients with type 2 diabetes will develop severe complications before symptoms develop.
Enable Biosciences Receives $3M SBIR Grant for Type 1 Diabetes Test
The company is developing a dried blood spot test for type 1 diabetes autoantibodies and intends to use the funding to pursue FDA clearance.
Proteomics International Expects Licensing Deal, Medicare Coverage to Drive PromarkerD Sales in 2024
Premium
The company is making its first major commercial push for its diabetic kidney disease test via a US licensing deal it inked this spring with Sonic Healthcare.
WHO Adds Hepatitis E to Essential Dx List
The new edition of the essential diagnostics list recommends tests for infectious diseases, maternal and newborn health, and chronic diseases, among others.
Sonic Healthcare USA Licenses Proteomics International Kidney Disease Test
The PromarkerD blood test predicts a decline in kidney function in patients with type 2 diabetes by measuring three serum protein biomarkers and three clinical variables.